M&A / Deals Deep Science Ventures and MDC partner to accelerate brain treatments PharmaTimesNew collaboration aims to break barriers in braintargeted drug discoveryNeuroscienceRead full story pharminent June 2, 2026 (Last updated: June 4, 2026) PharmaTimes New collaboration aims to break barriers in braintargeted drug discovery Neuroscience Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: BMS secures FDA acceptance for Camzyos sNDANext: Abivax slides on phase 3 data in ulcerative colitis Related Stories M&A / Deals Spero snaps up Innovent immunology drug in strategic pivot pharminent July 14, 2026 M&A / Deals AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B pharminent July 14, 2026 M&A / Deals Novartis and Chai Discovery collaborate on antibody identification pharminent July 14, 2026
